Generic Logo

Working At Asterias Biotherapeutics

Zippia Score 4.0

Asterias Biotherapeutics overview

Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapies in the fields of cell therapy and regenerative medicine. The company develops therapeutic products in the areas of neurology and oncology. Its clinical stage programs include AST-OPC1, a therapy derived from pluripotent stem cells that has completed a Phase I clinical trial for the treatment of thoracic spinal cord injuries; and that is in Phase I/IIa clinical trial for treating cervical spinal cord injuries, as well as for the treatment of multiple sclerosis and white matter stroke. The company also develops immunotherapeutic programs, such as AST-VAC1, an autologous product candidate that has completed a Phase II clinical trial for the treatment of acute myelogenous leukemia; and AST-VAC2, which is in a Phase I/IIa clinical trial, an allogeneic and cancer vaccine candidate designed to stimulate patient immune responses to telomerase. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California. Asterias Biotherapeutics, Inc. is a subsidiary of BioTime, Inc.
The average employee at Asterias Biotherapeutics makes $85,773 per year, which is competitive for its industry and location. Some of its highest paying competitors, Ansun Biopharma, Progenitor Life Sciences, and Puzzlium, pay $111,751, $93,896, and $82,557, respectively.
Asterias Biotherapeutics is a small technology company based in Menlo Park, California with only 55 employees and an annual revenue of $6.2M.

Industry

Biotechnology

Revenue

$6.2M

Employees

55

Founded in

2012

Headquarters

Menlo Park, CA

Website

lineagecell.com

Website

lineagecell.com

Organization Type

-

Is This Your Company?

The team at Asterias Biotherapeutics

Key People
  • Robert Peabody (Executive Officer, Director)
  • Alfred Kingsley (Director)
  • Judith Segall (Executive Officer, Director)
  • Pedro Lichtinger (Executive Officer, Director)
  • Michael West (Executive Officer, Director)
  • Katharine Spink (Executive Officer)
  • Andrew Arno (Director)
  • Richard Lebuhn (Director)
  • Natale Ricciardi (Director)
  • Jane Lebkowski (Executive Officer)

What do people say about Asterias Biotherapeutics

Do you work at Asterias Biotherapeutics ? Anonymously review Asterias Biotherapeutics as an Employer.

What Do You Like About Working For Asterias Biotherapeutics?

Asterias Biotherapeutics Rankings

Asterias Biotherapeutics is ranked #5 on the Best Technology Companies to Work For in Menlo Park, CA list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

00

Do you Work At Asterias Biotherapeutics?

Help us make this company more transparent.

Asterias Biotherapeutics Financial Performance

6.2
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Revenue

$5M - $10M

Founded in

2012

Organization type

-

Asterias Biotherapeutics Financing Rounds

DateAmount
Feb 23, 2015Equity
$4,000,000
Jun 20, 2014Options
$11,700,000
Jun 19, 2014Equity
$3,276,000

How Would You Rate The Company Culture Of Asterias Biotherapeutics?

Have you worked at Asterias Biotherapeutics? Help other job seekers by rating Asterias Biotherapeutics.

Asterias Biotherapeutics Competitors

Company
Ansun BiopharmaBiotechnology

Avg: $111,751

Progenitor Life SciencesBiotechnology

Avg: $93,896

PuzzliumInternet Software & Services

Avg: $82,557

Gadget SoftwareInternet Software & Services

Avg: $82,208

SalesWiseInternet Software & Services

Avg: $78,631

Frequently Asked Questions about Asterias Biotherapeutics

When was Asterias Biotherapeutics founded?

Asterias Biotherapeutics was founded in 2012.

How many Employees does Asterias Biotherapeutics have?

Asterias Biotherapeutics has 55 employees.

How much money does Asterias Biotherapeutics make?

Asterias Biotherapeutics generates $6.2M in revenue.

What industry is Asterias Biotherapeutics in?

Asterias Biotherapeutics is in the biotechnology industry.

Who are Asterias Biotherapeutics's competitors?

Asterias Biotherapeutics competitors include Kala Pharmaceuticals, Baebies, Inc., Ativa Medical Corporation, Aspen Mountain Medical Center, Gadget Software, BotFactory Inc., Arcbazar.com, Inc., nanoRETE, Inc., Puzzlium Inc., Neosync, Progenitor Life Sciences LLC, Jumprope, Inc., Cricket Health Inc., Verato, Inc., Corvia Medical, Mursion, Inc., Ansun Biopharma, ShotTracker Inc., SalesWise, Inc., Liveleaf, Inc..

Who works at Asterias Biotherapeutics?

Robert Peabody (Executive Officer, Director)

Alfred Kingsley (Director)

Judith Segall (Executive Officer, Director)

Show More

Where is Asterias Biotherapeutics's headquarters?

Asterias Biotherapeutics's headquarters is in Menlo Park, CA.

What is Asterias Biotherapeutics's website?

You can find the Asterias Biotherapeutics website at lineagecell.com.

Are you an executive, HR leader, or brand manager at Asterias Biotherapeutics?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at Asterias Biotherapeutics, also known as ASTERIAS BIOTHERAPEUTICS INC, Asterias Biotherapeutics Inc and Asterias Biotherapeutics, Inc..

Zippia gives an in-depth look into the details of Asterias Biotherapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Asterias Biotherapeutics. The employee data is based on information from people who have self-reported their past or current employments at Asterias Biotherapeutics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Asterias Biotherapeutics and its employees or that of Zippia.